Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal.

Elisei, R; Schlumberger, M; Driedger, A; Reiners, C; Kloos, R T; Sherman, S I; Haugen, B; Corone, C; Molinaro, E; Grasso, L; Leboulleux, S; Rachinsky, I; Luster, M; Lassmann, M; Busaidy, N L; Wahl, R L; Pacini, F; Cho, S Y; Magner, J; Pinchera, A; Ladenson, P W

Elisei, R; Schlumberger, M; Driedger, A; Reiners, C; Kloos, R T; Sherman, S I; Haugen, B; Corone, C; Molinaro, E; Grasso, L; Leboulleux, S; Rachinsky, I; Luster, M; Lassmann, M; Busaidy, N L; Wahl, R L; Pacini, F; Cho, S Y; Magner, J; Pinchera, A; Ladenson, P W.

Affiliation

Elisei R; Department of Endocrinology, University of Pisa, 56124 Pisa, Italy. relisei@endoc.med.unipi.it

J Clin Endocrinol Metab ; 94(11): 4171-9, 2009 Nov.

Article in En | MEDLINE | ID: mdl-19850694

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Hormones / Thyroid Neoplasms / Thyrotropin / Iodine Radioisotopes Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Endocrinol Metab Year: 2009 Document type: Article Affiliation country: Italia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google